Last reviewed · How we verify
Group IVC
At a glance
| Generic name | Group IVC |
|---|---|
| Sponsor | Kasr El Aini Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer (NA)
- Comparison Between Using Cardiometry and IVC Collapsibility
- Preoperative Evaluation of IVC Collapsibility Index and Caval Aorta Index After Induction of General Anesthesia
- The Effect of CUGP Fluid Management in Patients With Sepsis or Septic Shock (NA)
- Use of Point-of-Care Ultrasound (POCUS) to Reduce Hospital Length of Stay in Patients With Heart Failure ( POCUSHF ) (NA)
- Comparison Between High and Low Level Para-aortic Lymphadenectomy in High and Intermediate Risk Endometrial Carcinoma (NA)
- Study Of Ultrasound Windows For Measuring Inferior Vena Cava Changes Before Cardiac Surgery
- Transhepatic Echography for Fluid Responsiveness After Cardiovascular Surgery
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Group IVC CI brief — competitive landscape report
- Group IVC updates RSS · CI watch RSS
- Kasr El Aini Hospital portfolio CI